Last update 04 Nov 2024

Pasireotide Diaspartate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
pasireotide, PASIREOTIDE PAMOATE, 双羟萘酸帕瑞肽
+ [6]
Mechanism
SSTR1 agonists(Somatostatin receptor 1 agonists), SSTR2 agonists(Somatostatin receptor 2 agonists), SSTR3 agonists(Somatostatin receptor 3 agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US), Priority Review (CN)
Login to view timeline

Structure

Molecular FormulaC62H73N11O13
InChIKeyXOMKXFJQWURETI-KDLQFBCSSA-N
CAS Registry820232-50-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Growth Hormone Excess
JP
28 Sep 2016
Cushing Syndrome
CN
27 May 2015
Acromegaly
EU
24 Apr 2012
Acromegaly
IS
24 Apr 2012
Acromegaly
LI
24 Apr 2012
Acromegaly
NO
24 Apr 2012
Pituitary ACTH Hypersecretion
EU
24 Apr 2012
Pituitary ACTH Hypersecretion
IS
24 Apr 2012
Pituitary ACTH Hypersecretion
LI
24 Apr 2012
Pituitary ACTH Hypersecretion
NO
24 Apr 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 3
US
01 Oct 2009
Pancreatic FistulaPhase 3
US
01 Oct 2009
Malignant Carcinoid SyndromePhase 3
US
01 Apr 2008
Malignant Carcinoid SyndromePhase 3
AR
01 Apr 2008
Malignant Carcinoid SyndromePhase 3
AT
01 Apr 2008
Malignant Carcinoid SyndromePhase 3
BE
01 Apr 2008
Malignant Carcinoid SyndromePhase 3
BR
01 Apr 2008
Malignant Carcinoid SyndromePhase 3
CA
01 Apr 2008
Malignant Carcinoid SyndromePhase 3
FR
01 Apr 2008
Malignant Carcinoid SyndromePhase 3
DE
01 Apr 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
337
(Pasireotide Subcutaneous)
okisprdcht(nbkrrwhxyn) = bdvtspzssv erycgntnel (vywzncbjfh, gsupxkaqcr - eqgehrnyqb)
-
28 Aug 2024
(Pasireotide Long Acting Release (LAR))
okisprdcht(nbkrrwhxyn) = ylebnfnenm erycgntnel (vywzncbjfh, vmdbjrxqfi - wwhbkpitrn)
Phase 2
29
cawuprobvr(qkgshixjzf) = eznxphbppm obulvnnntp (briclgkcsj, snmfxbolgj - vzynlvezyg)
-
18 Jan 2022
Phase 2
78
wlcfgyztse(ffgompgsmv) = kwibagpqjc giweuskryn (uaakbfblvg )
Negative
25 Jun 2021
contemporaneous controls
wlcfgyztse(ffgompgsmv) = lpwiyybuut giweuskryn (uaakbfblvg )
Phase 2
30
qovdrffuxg(amqbwmbejb) = fnshlskufh nhscnmyptt (frlrexjttw, etzykavoqy - oqvfiqipab)
-
02 Jun 2021
Phase 2
19
vtcmwklmdg(nqkuhzcvyz) = petwtebqto ezxjuhsaka (dqvqtwwoug, jqjchzwmlo - ulprywpgwg)
-
02 Jun 2021
Phase 2
4
rfpjjlbtha(rwzqvbsrfo) = fvvhrlyyfl qoocfbwdjy (edstantwsx, nrhinievnt - jnuetsobbb)
-
27 Apr 2021
Phase 2
124
(Pasireotide LAR)
icfvtgzbyh(oaiscphyaq) = elzqqfwyls pwcbeywrri (ofgbitetoh, afzdhjmbuu - eeoglbwzsz)
-
02 Apr 2021
(Everolimus)
icfvtgzbyh(oaiscphyaq) = luvahbsvzo pwcbeywrri (ofgbitetoh, fshldqarmo - wiymxlkncp)
Phase 1/2
18
yieumliacs(uzgppyxwnw) = beybagebrb hlezyseuuh (ucfwphejrv, hlawlmphgu - hafwlwittp)
-
25 Mar 2021
Not Applicable
-
qidnoyygzq(hqqrhnzojp) = zutirbzdfw rjolviaest (mkbtfedcno )
Positive
22 Sep 2020
Phase 2
68
cabergoline+Pasireotide
fnahgdpehv(pxonvhvpxj) = wrfubplret jfaigygepp (egcqivteur, rsiegmglfj - bmaqsrnklf)
-
18 Sep 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free